VIATORR Device Registry

The primary objective is to confirm the clinical performance and safety of the GORE® VIATORR® TIPS (Transjugular Intrahepatic Portosystemic Shunt) Endoprosthesis with Controlled Expansion throughout the device functional lifetime of 3 years in real world setting.The secondary objective is to collect information on quality of life after treatment with the GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion.Additionally, data will be collected on the safety and performance of the GORE TIPS Set when utilized.

Inclusion Criteria:Patient is eligible for treatment with the GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion for TIPS creationPatient is ≥18 years of ageCapable of complying with protocol requirements, including follow-upSigned informed consent by patientExclusion Criteria:Unable or not willing to sign informed consentPatient is enrolled in an investigational studyPatient has been previously enrolled in this registryPregnant or breastfeeding female at time of informed consent signatureAny other condition which in the judgement of the investigator would preclude adequate registry participation